These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38642210)
1. Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study. Rui M; Jiang L; Pan JJ; Huang XT; Cui JF; Zhang SJ; He SM; Han HH; Chen X; Wang DD Int Urol Nephrol; 2024 Sep; 56(9):3047-3055. PubMed ID: 38642210 [TBL] [Abstract][Full Text] [Related]
2. Tacrolimus in resistant primary membranous nephropathy--a report of 3 cases. Szeto CC; Leung CB; Lai FM; Li PK Clin Nephrol; 2003 Apr; 59(4):293-6. PubMed ID: 12708570 [TBL] [Abstract][Full Text] [Related]
3. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy. Peng L; Wei SY; Li LT; He YX; Li B J Formos Med Assoc; 2016 Jan; 115(1):11-8. PubMed ID: 26315481 [TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy. Liang Q; Li H; Xie X; Qu F; Li X; Chen J Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168 [TBL] [Abstract][Full Text] [Related]
5. Electron-Dense Deposition Patterns and the Outcomes of Nephrotic Idiopathic Membranous Nephropathy Treated with Tacrolimus in Chinese Adults. Xiang X; Feng Z; Jiang Q; Huang D; Meng Z; Luo Z Med Sci Monit; 2021 Apr; 27():e930500. PubMed ID: 33896931 [TBL] [Abstract][Full Text] [Related]
6. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial. Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759 [TBL] [Abstract][Full Text] [Related]
7. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria. Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tacrolimus-based treatment for nephrotic idiopathic membranous nephropathy in young adults: A retrospective study. Zhang XJ; Ji CF; Yuan JZ; Wang L; Zhang J; Fang W; Bai DF; Hu Z Kaohsiung J Med Sci; 2019 Oct; 35(10):633-639. PubMed ID: 31225949 [TBL] [Abstract][Full Text] [Related]
10. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study. Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083 [TBL] [Abstract][Full Text] [Related]
11. Detection and clinical significance of glomerular M-type phospholipase A Liu H; Luo W; Gong S; Ding X Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390 [TBL] [Abstract][Full Text] [Related]
12. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome. Yuan H; Liu N; Sun GD; Jia Y; Luo P; Miao LN Pharmacology; 2013; 91(5-6):259-66. PubMed ID: 23652322 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis. Lin W; Li HY; Lin S; Zhou T Drug Des Devel Ther; 2019; 13():2179-2186. PubMed ID: 31308629 [TBL] [Abstract][Full Text] [Related]
14. New-Onset Diabetes Mellitus in Patients with Idiopathic Membranous Nephropathy Undergoing Tacrolimus and Low-Dose Corticosteroid Therapy. Shao L; Jin J; Ye B; Xu B; Li Y; Gong J; Zhang J; Chen M; He Q Kidney Blood Press Res; 2019; 44(6):1352-1362. PubMed ID: 31645044 [TBL] [Abstract][Full Text] [Related]
15. Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety. Yang S; Xie L; Xue W; Yin A; Lu W Nephrology (Carlton); 2013 Sep; 18(9):615-22. PubMed ID: 23889815 [TBL] [Abstract][Full Text] [Related]
16. Effect of tacrolimus in idiopathic membranous nephropathy: a meta-analysis. Santosh T; Liu H; Liu B Chin Med J (Engl); 2014; 127(14):2693-9. PubMed ID: 25043091 [TBL] [Abstract][Full Text] [Related]
17. The calcineurin regulatory subunit polymorphism and the treatment efficacy of tacrolimus for idiopathic membranous nephropathy. Zhu Y; Zhang M; Wang F; Lu J; Chen R; Xie Q; Sun J; Xue J; Hao C; Lin S Int Immunopharmacol; 2018 Dec; 65():422-428. PubMed ID: 30388516 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and safety of different tacrolimus concentrations for the treatment of patients with idiopathic membranous nephropathy. Wang Q; Li M; Cheng X; Xu G Sci Rep; 2021 Jun; 11(1):13274. PubMed ID: 34168218 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy. Zou H; Jiang F; Xu G Ren Fail; 2019 Nov; 41(1):673-681. PubMed ID: 31354007 [No Abstract] [Full Text] [Related]
20. Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy. Shang SL; Cai GY; Duan SW; Li P; Li QG; Chen XM BMC Nephrol; 2018 Jul; 19(1):182. PubMed ID: 30021637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]